Invesco India Contra Fund: Identifying Stocks in a Turnaround Phase

Invesco India Contra Fund is a Contra Fund known for its ability to realise the full potential of its contrarian stock picks, that has helped generate reasonable risk-adjusted returns and create significant wealth for its investors in the long run.

Data as on February 09, 2022
(Source: ACE MF)

Invesco India Contra Fund has time and again maintained its spot as a top contender in the Contra Funds category. It has distinctly outperformed the benchmark S&P BSE 500 - TRI across most time periods in the past. Notably, Invesco India Contra Fund has trailed the benchmark and the category average in the last one and a half year which has impacted its performance over the medium term. However, the fund's returns over longer time periods of 3-years, 5-years, and 7-years have been remarkable, where it has managed to generate an alpha of around 1-3.5 percentage points.

Invesco India Contra Fund has shown volatility nearly in line with the benchmark and has been effective in generating superior risk-adjusted returns for its long-term investors. The fund's Sharpe ratio of 0.23 is ahead of the benchmark, thus making it a prominent contender in the category.

Investment strategy of Invesco India Contra Fund

Invesco India Contra Fund follows a contrarian strategy where the fund managers pick 'neglected stocks' with strong asset values while focusing on under-owned sectors carrying high potential. The aim is to have a first-mover advantage by investing in out of favour sectors/stocks, thus increasing performance prospects. In terms of asset allocation, the fund is mandated to invest a minimum of 65% of its assets in equity and equity-related instruments, and a maximum of 35% can be invested in debt and money market instruments.

While managing Invesco India Contra Fund, the fund managers focus on undervalued stocks trading at a significant discount to their fair valuation with an aim to hold them in the portfolio until their intrinsic value is achieved. Accordingly, the fund managers identify and invest in potentially undervalued stocks across sectors utilizing both the top-down and bottom-up approach and believe in incubating such stocks for a while before they find favour with the rest of the market.

The fund managers also try to proactively identify new investment themes. It also examines the relative attractiveness of mid-caps and large caps and adjusts the market cap of the portfolio towards higher return potential. While the fund managers constantly hunt for stocks available at cheap valuations and look at timely entry and exit, moderate churning in Invesco India Contra Fund's portfolio cannot be ruled out.

Invesco India Contra Fund usually holds a well-diversified portfolio of 45-55 stocks at any point of time. As of January 31, 2022, the fund held 52 stocks in its portfolio, with the top 10 stock holdings accounting for nearly 48.1% of its assets. Highly liquid names like ICICI Bank, HDFC Bank, and Infosys currently appear among the top holdings in the fund's portfolio. SBI, L&T, Reliance Industries, Ultratech Cement, etc. currently stand among the other top holdings in the portfolio. Most of them have been among the core contenders in the fund's portfolio for a long time.

ICICI Bank, Infosys, Reliance Industries, KEI Industries, L&T, Bharat Electronics, Tech Mahindra, and Ultratech Cement were among the stocks that turned out to be the top contributors to Invesco India Contra Fund's performance in the last one year. However, it lost some value in stocks such as, Aurobindo Pharma, Rallis India, and Mishra Dhatu Nigam.

In terms of sector concentration, the top five sectors in Invesco India Contra Fund's portfolio accounted for nearly 60% of its assets. The fund held higher weightage to Banking & Finance stocks together accounting for 31.9% of its assets, followed by Infotech (11.6%), Engineering (8.9%), Auto (7.3%), and Pharma (6.1%). Consumption, Cement, Power, and Petroleum are among the other prominent sectors in the fund's portfolio.

Suitability

Invesco India Contra Fund is a process-driven fund that holds a superior performance track record that speaks about its ability to create wealth for investors. The fund managers, Mr Taher Badshah and Dhimant Kothari bring immense experience to the fund. With this, Invesco India Contra Fund has delivered market-beating returns across time periods and market cycles.

The fund is well-equipped to capitalise on various market opportunities. While Invesco India Contra Fund has the ability to manage downside risk during extreme market conditions, it can gear up and actively participate in the market rallies too. The fund gives high weightage to fundamentals, long-term price momentum, and outlook of stocks in its portfolio. This helps it maintain a lead over its peers during uncertain market phases.

As mentioned earlier, contra funds invest in 'out-of-favour' themes, and therefore they may temporarily underperform in the short term. This makes Invesco India Contra Fund suitable for investors with high risk tolerance and a time horizon of at least 5 years.

Warm Regards,
Divya Grover
Research Analyst

PS: If you are looking for quality mutual fund schemes (including Equity-linked Saving Schemes) to add to your investment portfolio, I suggest you subscribe to PersonalFN's premium research service, FundSelect. PersonalFN's FundSelect service provides insightful and practical guidance on which mutual fund schemes to Buy, Hold, and Sell.

Currently, with the subscription to FundSelect, you could also get Free Bonus access to PersonalFN's Debt Fund recommendation service   DebtSelect.

If you are serious about investing in a rewarding mutual fund scheme, subscribe now!

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.

Join Now: PersonalFN is now on Telegram. Join FREE Today to get ‘Daily Wealth Letter’ and Exclusive Updates on Mutual Funds

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

1. Money Simplified Services Private Limited;

2. PersonalFN Insurance Services India Private Limited;

3. Equitymaster Agora Research Private Limited;

4. Common Sense Living Private Limited;

5. Quantum Advisors Private Limited;

6. Quantum Asset Management Company Private Limited;

7. HelpYourNGO.com India Private Limited;

8. HelpYourNGO Foundation;

9. Natural Streets for Performing Arts Foundation;

10. Primary Real Estate Advisors Private Limited;

11. HYNGO India Private Limited;

12. Suresh Lulla;

13. I V Subramaniam;

14. Murali Ananthan Krishnan.

1. ‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;

2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company; except for one of the Research Analysts holding units of Invesco India Contra Fund;

3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

1. The Research Analyst has not served as an officer, director or employee of the subject Company.

2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Click here to read PersonalFN's Mutual Fund Rating Methodology

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021

Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013